Novel anti-flavivirus drugs targeting the nucleolar distribution of core protein (Q91887815)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31826845%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

title

Novel anti-flavivirus drugs targeting the nucleolar distribution of core protein (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31826845%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

author name string

Makoto Tokunaga

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31826845%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Yoichi Miyamoto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31826845%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Tatsuya Suzuki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31826845%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Mayumi Otani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31826845%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Shinsuke Inuki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31826845%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Tsuyoshi Esaki

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31826845%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Chioko Nagao

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31826845%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Hiroaki Ohno

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31826845%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Yoshihiro Yoneda

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31826845%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Toru Okamoto

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31826845%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Masahiro Oka

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31826845%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

publication date

29 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31826845%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31826845%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

volume

541

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31826845%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

page(s)

41-51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31826845%20AND%20SRC:MED&resulttype=core&format=json

Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity

25 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Cyclin-dependent kinase 9 links RNA polymerase II transcription to processing of ribosomal RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Modulation of cytokine and cytokine receptor/antagonist by treatment with doxycycline and tetracycline in patients with dengue fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Flavopiridol inhibits P-TEFb and blocks HIV-1 replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

West Nile virus neuroinvasive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

The small molecules AZD0530 and dasatinib inhibit dengue virus RNA replication via Fyn kinase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Refined efficacy estimates of the Sanofi Pasteur dengue vaccine CYD-TDV using machine learning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Reoptimization of MDL keys for use in drug discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Novel dengue virus inhibitor 4-HPR activates ATF4 independent of protein kinase R-like Endoplasmic Reticulum Kinase and elevates levels of eIF2α phosphorylation in virus infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

ChEMBL: a large-scale bioactivity database for drug discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

MDMX regulation of p53 response to ribosomal stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Inhibitors of nuclear transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Zika and the Risk of Microcephaly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Regulation of ribosome biogenesis within the nucleolus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Small Molecule Inhibitors That Selectively Block Dengue Virus Methyltransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Molecular biology of flaviviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Regulation of HDM2 activity by the ribosomal protein L11

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Overview: Japanese encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Nuclear localization of Japanese encephalitis virus core protein enhances viral replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

A structural perspective of the flavivirus life cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Conformational Flexibility of the Dengue Virus RNA-Dependent RNA Polymerase Revealed by a Complex with an Inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Complementation of placental defects and embryonic lethality by trophoblast-specific lentiviral gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Resistance of Hepatitis C Virus to Inhibitors: Complexity and Clinical Implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

A small molecule fusion inhibitor of dengue virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

The nucleolar interface of RNA viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Viral regulation of host cell biology by hijacking of the nucleolar DNA-damage response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Membranous replication factories induced by plus-strand RNA viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Efficacy, immunogenicity and safety of a recombinant tetravalent dengue vaccine (CYD-TDV) in children aged 2-17 years: systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Use of pentoxifylline in treatment of children with dengue hemorrhagic fever.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Viruses and the nucleolus: the fatal attraction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex virus DNA synthesis in the presence of viral early proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Characterization and prediction of protein nucleolar localization sequences.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Cyclin-dependent kinases govern formation and maintenance of the nucleolus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Infection with flaviviruses requires BCLXL for cell survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Correction: Development of oligonucleotide-based antagonists of Ebola virus protein 24 inhibiting its interaction with karyopherin alpha 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

A small-molecule dengue virus entry inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Stabilization of p53 in influenza A virus-infected cells is associated with compromised MDM2-mediated ubiquitination of p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

The non-structural (NS1) protein of influenza A virus associates with p53 and inhibits p53-mediated transcriptional activity and apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Zika virus: History, emergence, biology, and prospects for control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Composition and three-dimensional architecture of the dengue virus replication and assembly sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Phase I clinical and pharmacokinetic study of flavopiridol in children with refractory solid tumors: a Children's Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Novel dengue virus-specific NS2B/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Novel Flavivirus Antiviral That Targets the Host Nuclear Transport Importin α/β1 Heterodimer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

PaDEL-descriptor: An open source software to calculate molecular descriptors and fingerprints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

An adenosine nucleoside inhibitor of dengue virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Cyclin T1/CDK9 interacts with influenza A virus polymerase and facilitates its association with cellular RNA polymerase II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

Characterization of the E-138 (Glu/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2019.11.015

10.1016/J.VIROL.2019.11.015

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31826845%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

1 reference